Supplement
Effectiveness scores 64 due to solid nutrient coverage (e.g., 500mg C, 2000IU D3 backed by meta-analyses for immune/cognitive support) but weak evidence for brain claims; RCTs like COSMOS trial (PubMed 37285398) show multivitamins slow cognitive aging modestly (60mg/day slowdown), yet brain-specific ingredients underdosed (PS 25mg vs. 100mg in RCTs for memory). Safety at 77 reflects low risks for most but vinpocetine FDA exclusion and interactions (anticoagulants). Quality 72 for transparency/GM
Good (68/100) - Effectiveness scores 64 due to solid nutrient coverage (e.g., 500mg C, 2000IU D3 backed by meta-analyses for immune/cognitive support) but weak evidence for brain claims; RCTs like COSMOS trial (PubMed 37285398) show multivitamins slow cognitive aging modestly (60mg/day slowdown), yet brain-specific ingredients underdosed (PS 25mg vs. 100mg in RCTs for memory). Safety at 77 reflects low risks for most but vinpocetine FDA exclusion and interactions (anticoagulants). Quality 72 for transparency/GMP but lacks third-party verification, leading to average overall (68) vs. premium tested multis scoring 80+.